These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 489719)

  • 1. Low renin essential hypertension: failure to demonstrate excess 11-deoxycorticosterone production.
    Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1979 Nov; 49(5):790-3. PubMed ID: 489719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
    Gomez-Sanchez CE; Holland OB; Upcavage R
    J Clin Endocrinol Metab; 1985 Feb; 60(2):234-8. PubMed ID: 3880766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
    Melby JC; Dale SL
    Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 11-deoxycorticosterone in human hypertension.
    Tan SY; Noth RH; Mulrow PJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():311s-314s. PubMed ID: 1071634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unconjugated and conjugated urinary 19-nor-deoxycorticosterone glucosiduronate. Elevated levels in essential hypertension.
    Griffing GT; Wilson TE; Melby JC
    Hypertension; 1985; 7(3 Pt 2):I12-7. PubMed ID: 3873413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitory increment in urinary free 19-nor-deoxycorticosterone after diuretic-induced renin stimulation.
    Griffing GT; Wilson TE; Melby JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):931-5. PubMed ID: 6480812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man.
    Ojima M; Aida M; Kambegawa A
    Tohoku J Exp Med; 1978 Apr; 124(4):367-79. PubMed ID: 663934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
    Williams GH; Braley LM; Underwood RH
    J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism].
    Chamontin B; Blanchouin-Emeric N; Amar J; Khatibi F; Vernier I; Bennet A; Aupetit-Faisant B; Salvador M
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1055-8. PubMed ID: 8949378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated urinary 19-Nor-deoxycorticosterone glucuronide in Cushing's syndrome.
    Ehlers ME; Griffing GT; Wilson TE; Melby JC
    J Clin Endocrinol Metab; 1987 May; 64(5):926-30. PubMed ID: 3558730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity.
    Messerli FH; Kuchel O; Nowaczynski W; Seth K; Honda M; Kubo S; Boucher R; Tolis G; Genest J
    Circulation; 1976 Mar; 53(3):406-10. PubMed ID: 1248073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome.
    Brown JJ; Fraser R; Love DR; Ferriss JB; Lever AF; Robertson JI; Wilson A
    Lancet; 1972 Aug; 2(7771):243-7. PubMed ID: 4114505
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
    Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.